Search for: "APP Pharmaceuticals, LLC" Results 81 - 100 of 133
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Sep 2012, 7:52 am by Evan Brown (@internetcases)
App., September 4, 2012) Appellant, a healthcare clinic organized as an LLC in Minnesota, got sued in Tennessee. [read post]
27 Aug 2012, 9:31 am by Gene Quinn
., and APP Pharmaceuticals, LLC filed abbreviated new drug applications ("ANDAs") seeking approval to manufacture and sell generic versions of Alimta® before the expiration of the '932 patent. [read post]
23 Apr 2012, 1:46 pm
Here are a few we have blogged about: Eli Lilly and Company Sues Accord Healthcare for Patent Infringement of Lung Cancer Drug ALIMTA Eli Lilly Company Sues APP Pharmaceuticals LLC for Patent Infringement of Chemotherapy Drug Lilly Wins Patent Infringement Suit Regarding Chemotherapy Drug [read post]
1 Mar 2012, 3:45 am
Abraxis Pharmaceutical Products, or APP Pharmaceuticals, is major, international pharmaceutical conglomerate centered in the suburbs of Chicago, Illinois. [read post]
9 Feb 2012, 4:06 pm by FDABlog HPM
ANDA sponsor APP Pharmaceuticals, LLC (“APP”) attempted to intervene in the PTE litigation before Judge Hilton; however, APP’s Motion to Intervene was denied.  [read post]
13 Jan 2012, 8:16 am
The Consumer Electronics Association, which is behind the show, has been a vocal opponent of the two bills circulating in Congress that would help Hollywood titans, record labels and pharmaceutical firms enforce copyright infringement laws online. [read post]
12 Jan 2012, 1:15 pm by Bexis
“[W]e are troubled by the lack of uniformity and certainty inherent in the case-by-case approach and fear the resulting disincentive for pharmaceutical manufacturers to develop new products.”   [read post]
2 Dec 2011, 2:00 pm by Bexis
APP Pharmaceuticals, LLC, 783 F. [read post]
14 Nov 2011, 4:46 pm by FDABlog HPM
Court of Appeals for the Federal Circuit notifying the Court of the enactment of Section 37 and asserting that it resolves the merits of the ongoing ‘404 patent PTE litigation with ANDA sponsor APP Pharmaceuticals, LLC (“APP”).  [read post]
20 Oct 2011, 7:55 am by FDABlog HPM
Court of Appeals for the Federal Circuit notifying the Court of the enactment of Section 37 and asserting that it resolves the merits of the ongoing ‘404 patent PTE litigation with APP Pharmaceuticals, LLC (“APP”) (see our previous posts here, here, and here).  [read post]
26 Sep 2011, 12:30 pm by FDABlog HPM
Court of Appeals for the Federal Circuit (where APP Pharmaceuticals, LLC (“APP”) has been duking it out with MDCO – see here and here) given all of the twists and turns that have occurred with the ANGIOMAX ‘404 patent PTE over the years.     [read post]